Top accelerator startups

14,448 startups · 29 programs

Isabl

Active · Cancer tests based on whole genome and transcriptome data.

8signal of 100 · rising 1
  • team of 5Team size · YC's directory+4
  • went through YCProgram · this site+4

A sum of public facts, not a judgement and not investment advice.

Competitors

Adjacent

Also from W20

All of W20

About Isabl

Isabl has developed software that can analyze the entire genome of cancer patients. Today, when people get cancer, they get a genetic test of their tumor that analyzes only a few possible mutations. With Isabl, you run the tumor through an Illumina sequencer and get the whole genome, then our software is able to analyze all the mutations. Our breakthrough technology provides unprecedented clarity into tumor biology to aid treatment planning. This opens up opportunities for precision diagnostics, disease surveillance and biomarker discovery.

YC batch
W20 · Winter 2020
Status, per YC
Active
Category
Other
Team size
5
Location
New York City, NY, USA; New York, NY, USA; Remote
Checked
6h ago

YC tags: Biotech, Diagnostics

Isabl in W20: 229 companies, 29% AI

Isabl: questions

Which YC batch was Isabl in?

Isabl was in Y Combinator's Winter 2020 batch (W20).

Is Isabl still active?

Y Combinator lists Isabl as active.

Where is Isabl based?

Isabl lists New York City, NY, USA; New York, NY, USA; Remote as its location on YC's directory.